不感兴趣
发表于 2025-3-25 04:47:14
http://reply.papertrans.cn/23/2219/221891/221891_21.png
词汇表
发表于 2025-3-25 10:41:15
http://reply.papertrans.cn/23/2219/221891/221891_22.png
demote
发表于 2025-3-25 12:34:40
http://reply.papertrans.cn/23/2219/221891/221891_23.png
FEAS
发表于 2025-3-25 18:55:12
Mechanisms of Cardiorenal Syndrome: From Molecular Pathways to Novel Therapeuticsel therapeutic for CRS and acute kidney injury (AKI). CRRL269 possesses renal enhancing properties with RAAS suppression and less hypotension than native NPs, thus representing a new and innovative drug for renoprotection in HF. The combination of using NP urinary biomarkers and designer NP therapeu
SEMI
发表于 2025-3-25 20:54:02
http://reply.papertrans.cn/23/2219/221891/221891_25.png
apiary
发表于 2025-3-26 02:08:42
http://reply.papertrans.cn/23/2219/221891/221891_26.png
HPA533
发表于 2025-3-26 06:00:10
A Patient with Abdominal Congestionvenous congestion. Interestingly, strategies that result in a resolution of the increased IAP in ADHF (e.g. paracentesis or ultrafiltration), have been shown to result in an improvement of renal function. This chapter focusses on the role of abdominal congestion in heart failure.
调整校对
发表于 2025-3-26 10:14:15
http://reply.papertrans.cn/23/2219/221891/221891_28.png
CBC471
发表于 2025-3-26 15:41:03
http://reply.papertrans.cn/23/2219/221891/221891_29.png
LARK
发表于 2025-3-26 18:32:12
S. Subramanian,J. R. W. Woittiezel therapeutic for CRS and acute kidney injury (AKI). CRRL269 possesses renal enhancing properties with RAAS suppression and less hypotension than native NPs, thus representing a new and innovative drug for renoprotection in HF. The combination of using NP urinary biomarkers and designer NP therapeu